Dolor Technologies
Stage
Unattributed | AliveTotal Raised
$800KLast Raised
$800K | 9 yrs agoAbout Dolor Technologies
Dolor Technologies is dedicated to the development of pain management and drug delivery devices. In the U.S., Dolor Technologies currently offers SphenoCath through regional distributors. SphenoCath is a single-use, disposable catheter that delivers medication through the nasal passages to a difficult-to-reach ganglion located at the back of the nose without needles, sprays, swabs or sedation.
Missing: Dolor Technologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Dolor Technologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Dolor Technologies Patents
Dolor Technologies has filed 5 patents.
The 3 most popular patent topics include:
- Anesthesia
- General anesthetics
- Local anesthetics
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/10/2012 | 1/1/2019 | Neurological disorders, Syndromes, Rare diseases, Analgesics, Chronic pain syndromes | Grant |
Application Date | 2/10/2012 |
|---|---|
Grant Date | 1/1/2019 |
Title | |
Related Topics | Neurological disorders, Syndromes, Rare diseases, Analgesics, Chronic pain syndromes |
Status | Grant |
Dolor Technologies Frequently Asked Questions (FAQ)
Where is Dolor Technologies's headquarters?
Dolor Technologies's headquarters is located at 10967 Topview Road, South Jordan.
What is Dolor Technologies's latest funding round?
Dolor Technologies's latest funding round is Unattributed.
How much did Dolor Technologies raise?
Dolor Technologies raised a total of $800K.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.